Evidence for the Presence of N-methyl-D-aspartate Receptors in the Ventral Tegmental Area of the Rat: an Electrophysiological in Vitro Study
Authors
Affiliations
Extracellular recordings were obtained from spontaneously active, presumed dopaminergic neurons of the ventral tegmental area (VTA) of the rat in a slice preparation. Bath-applied N-methyl-D-aspartate (NMDA) (1-20 microM) activated all neurons tested (n = 36). This effect was clearly concentration-dependent (n = 14), quickly reversible and reproducible. No bursting type of discharge was observed during NMDA infusion. The NMDA receptor blocker DL-2-amino-5-phosphonovaleric acid (50 microM) reversibly antagonized the increase in cell firing produced with 10 microM NMDA by 83.5 +/- 3% (mean +/- S.E.M.) (n = 8, P less than 0.05). Lowering the Mg2+ concentration of the perfusion fluid to one-third of its normal value significantly enhanced the excitatory effect of 5 microM NMDA (n = 7, P less than 0.05), but not of 500 nM carbachol (n = 6). Finally, NMDA did not modify the sensitivity of dopaminergic autoreceptors of VTA neurons (n = 8), when compared to controls (n = 10). These observations strongly support the presence of specific NMDA receptors in the VTA.
Polli F, Kohlmeier K World J Psychiatry. 2022; 12(2):212-235.
PMID: 35317337 PMC: 8900586. DOI: 10.5498/wjp.v12.i2.212.
D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine.
Betts J, Schweimer J, Burnham K, Burnet P, Sharp T, Harrison P Front Synaptic Neurosci. 2014; 6:11.
PMID: 24822045 PMC: 4014674. DOI: 10.3389/fnsyn.2014.00011.
Ducrot C, Fortier E, Bouchard C, Rompre P Front Syst Neurosci. 2013; 7:57.
PMID: 24106463 PMC: 3789217. DOI: 10.3389/fnsys.2013.00057.
Developmental pathology, dopamine, stress and schizophrenia.
Lodge D, Grace A Int J Dev Neurosci. 2010; 29(3):207-13.
PMID: 20727962 PMC: 3022957. DOI: 10.1016/j.ijdevneu.2010.08.002.
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
Alex K, Pehek E Pharmacol Ther. 2006; 113(2):296-320.
PMID: 17049611 PMC: 2562467. DOI: 10.1016/j.pharmthera.2006.08.004.